NewLink’s stock tanks after earnings report, bear note
BPC Staff Aug 1, 2018 | 7:41 pm
<1 min read time
78 wordsAll Latest News, Health and Wellness, Insurance, Statewide NewsSchaeffer’s Investment Research: Biotechnology concern NewLink Genetics Corp. was down 20 percent this morning at $3 a share — a record low — after brokerage firm Stifel downgraded the stock to “hold” from “buy” and slashed its price target in half to $4. The bear note comes just after the Ames company on Tuesday reported a second-quarter loss of 47 cents per share and said it’s completed an organization realignment that reduced its head count by 30 percent.
Trending News
